Federal contractor · public award history
BIOAEGIS THERAPEUTICS INC
Parent: BIOAEGIS THERAPEUTICS INC Unique Entity Identifier (UEI)G2AZAC2PG7X3
- Awards we know about
- 1
- Typical size
- $20.00M
- Middle of their public awards
- Dollars on those awards
- $20.00M
Most of their awards we can see fall roughly between $20.00M and $20.00M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Dec 30, 2026
- Activation date
- Jan 1, 2026
- Primary NAICS (SAM)
- Research and Development in Biotechnology (except Nanobiotechnology)541714
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Health and Human Services (1)
Industries & product codes
Award history
- Department of Health and Human Services$20.00MSep 30, 2025Procurement Instrument Identifier (PIID)75A50123C00067Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
BIOAEGIS: PLASMA GELSOLIN (PGSN), AN ABUNDANT, CIRCULATING PROTEIN MODULATES INFLAMMATION WHILE ALSO ENHANCING HOST DEFENSES BY STIMULATING THE UPTAKE AND KILLING OF PATHOGENS. CLINICAL STUDIES HAVE CONSISTENTLY SHOWN PGSN IS DEPLETED IN SEVERE I
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.